Shelley Thunen
Director of Finance/CFO bei RXSIGHT, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Shelley B.
Thunen is currently a Non-Executive Director at AEON Biopharma Sub, Inc., a Director at Surface Ophthalmics, Inc., an Independent Director at AEON Biopharma, Inc., a Director at LENZ Therapeutics, Inc., and the Chief Financial Officer at RxSight, Inc. Previously, she served as an Independent Director at Restoration Robotics, Inc., the Chief Financial Officer, Director & VP-Operations at LenSx Lasers, Inc., a Director at eyeonics, Inc., the Chief Financial Officer at VitalCom, Inc., the Secretary, Chief Financial & Accounting Officer at Endologix LLC, the Chief Financial Officer & Executive Vice President at AMO Development LLC, the Chief Financial Officer, Secretary & EVP at VERSIFI, Inc., the Chief Financial Officer at TherOx, Inc., the Chief Financial Officer at Endologix, Inc., and the Associate General Manager at Alcon LenSx, Inc. Ms. Thunen obtained her undergraduate degree and MBA from the University of California, Irvine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RXSIGHT, INC.
0,06% | 01.04.2024 | 22 093 ( 0,06% ) | 1 Mio $ | 31.03.2024 |
-.--% | 21.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
| 19.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Shelley Thunen
| Unternehmen | Position | Beginn |
|---|---|---|
| RXSIGHT, INC. | Director of Finance/CFO | 01.02.2017 |
| AEON BIOPHARMA, INC. | Director/Board Member | 01.06.2023 |
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Director/Board Member | 01.08.2020 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Director/Board Member | 24.07.2023 |
Ehemalige bekannte Positionen von Shelley Thunen
| Unternehmen | Position | Ende |
|---|---|---|
| VENUS CONCEPT INC. | Director/Board Member | 01.11.2019 |
| ENDOLOGIX, INC. | Director of Finance/CFO | 15.10.2015 |
| Endologix, Inc. /Old/ | Director of Finance/CFO | 01.10.2015 |
| Alcon LenSx, Inc. | Corporate Officer/Principal | 31.12.2012 |
LenSx Lasers, Inc.
 LenSx Lasers, Inc. Medical SpecialtiesHealth Technology LenSx Lasers, Inc. develops computer-controlled and image-guided laser system. The company was founded by Juhasz Tibor, Weinberg Eric and Kurtz M. Ronald in 2008 and is headquartered in Aliso Viejo, CA. | Director of Finance/CFO | 01.08.2010 |
Ausbildung von Shelley Thunen
| University of California, Irvine | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RXSIGHT, INC. | Electronic Technology |
| AEON BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
VitalCom, Inc.
 VitalCom, Inc. Computer CommunicationsElectronic Technology VitalCom, Inc. provides patient monitoring networks and other communications products | Electronic Technology |
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
AMO Development LLC
 AMO Development LLC Medical SpecialtiesHealth Technology AMO Development LLC designs, develops and manufactures femtosecond laser technology for use in ophthalmology. It offers Keratoplasty a blade-free laser approach used to incise corneal tissue. The firm's products include metal cone and glass lens for disposable patient interface. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Technology |
Restoration Robotics, Inc.
 Restoration Robotics, Inc. Medical SpecialtiesHealth Technology Restoration Robotics, Inc. manufactures and develops medical devices for hair transplantation services. It provides artas system, a computer-assisted, physician-controlled system to harvest follicular units directly from the scalp. It operates in the United States, Europe and Middle East, Asia pacific, and Rest of the World. The company was founded by Mohan Bodduluri, Don Caddes, Phillip L. Gildenberg and Fredrick H. Moll on November 22, 2002 and is headquartered in San Jose, CA. | Health Technology |
LenSx Lasers, Inc.
LenSx Lasers, Inc. Medical SpecialtiesHealth Technology LenSx Lasers, Inc. develops computer-controlled and image-guided laser system. The company was founded by Juhasz Tibor, Weinberg Eric and Kurtz M. Ronald in 2008 and is headquartered in Aliso Viejo, CA. | Health Technology |
VERSIFI, Inc.
 VERSIFI, Inc. Packaged SoftwareTechnology Services Part of Reef NV, VERSIFI, Inc. is a digital asset trading and lending firm that combines a high-tech platform with high-touch services to help institutions trade and borrow efficiently. The private company is based in Newport Beach, CA. VERSIFI's plug-and-trade platform provides a single point of access for trading, borrowing, and lending, as well as custody services provided by third-party partners. Led by a team of proven industry professionals, VERSIFI is determined to help digital assets reach their fullest potential. | Technology Services |
TherOx, Inc.
 TherOx, Inc. Medical SpecialtiesHealth Technology TherOx, Inc. operates as a medical device company which focuses on developing and commercializing therapies to treat ischemic and oxygen deprived tissue. Its SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge that controls cartridge operation wherein SSO2 solution is created and mixed with the patient's blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded by David B. Musket, Paul J. Zalesky and J. Richard Spears in 1994 and is headquartered in Irvine, CA. | Health Technology |
eyeonics, Inc.
 eyeonics, Inc. Electronic ComponentsElectronic Technology eyeonics, Inc. designs, develops, manufactures and sells premium intraocular lenses. Its lenses are implantable devices that replace the natural lens in the human eye, typically after the natural lens has developed cataracts that can significantly impair vision. The firm's products are designed to both replace a cataractous lens and correct a refractive error. The company was founded by Andrew J. Corley and Stuart J. Cumming in 1998 and is headquartered in Aliso Viejo, CA. | Electronic Technology |
| Endologix, Inc. /Old/ | Health Technology |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Health Technology |
| Alcon LenSx, Inc. |
